Fusidic acid ring B hydroxylation by Cunninghamella elegans

Phytochemistry Letters

Volumn 25, Issue , 2018, Pages 86-89

  Ibrahim, Abdel Rahim S ^a   Ragab, Amany E ^a  

^a Tanta University   (Egypt)

Author keywords

C 6 hydroxylation; C 7 hydroxylation; Cunninghamella elegans; Fusidic acid

Indexed keywords

6 BETA HYDROXYFUSIDIC ACID; 7 BETA HYDROXYFUSIDIC ACID; ANTIINFECTIVE AGENT; FUSIDIC ACID; HYDROXYL GROUP; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BIOTRANSFORMATION; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL STRUCTURE; CONTROLLED STUDY; CUNNINGHAMELLA ELEGANS; HYDROXYLATION; MYCOBACTERIUM SMEGMATIS; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STEREOCHEMISTRY;

EID: 85045116747     PISSN: 18743900     EISSN: 18767486     Source Type: Journal    
DOI: 10.1016/j.phytol.2018.04.003     Document Type: Article

References (31)

1. Al-Footy, K.O., Biotransformation of some ring A and B epoxy steroids by the fungus Mucor plumbeus. Orient. J. Chem. 24:1 (2008), 1–6.
2. 5-androstenes by cephalosporium aphidicola. Phytochemistry 49:8 (1998), 2355–2358.
3. Berchtold, H., Reshetinova, L., Reiser, O.A., Schirmer, N.K., Sprinzl, M., Hilgenfeld, R., Crystal structure of the active elongation factor Tu reveals major domain rearrangements. Nature 365 (1993), 126–132.
4. Casillas, R.P., Crow, J., Heinze, T.M., Deck, J., Cerniglia, C.E., Initial oxidative and subsequent conjugative metabolites produced during the metabolism of phenanthrene by fungi. J. In. Microbial. 16:4 (1996), 205–215.
5. Cerniglia, C.E., Sutherland, J.B., Crow, S.A., Fungal metabolism of aromatic hydrocarbons. Winkelmann, G., (eds.) Microbial Degradation of Natural Products, 1992, VCH Publishers, Weinheim, Germany, 193–217.
6. Chang, T.K.H., Teixeira, J., Gil, G., Waxman, D.J., The lithocholic acid 6β-hydroxylase cytochrome P-450, CYP 3A10, is an active catalyst of steroid-hormone 6β-hydroxylation. Biochem. J. 291 (1993), 429–434.
7. Collignon, P., Turnidge, J., Fusidic acid in vitro activity. Int. J. Antimicrob. Agents 12 (1999), S45–S58.
8. Davis, P.J., Microbial models of mammalian drug metabolism. Dev. Ind. Microbiol. 29 (1988), 197–219.
9. Dvnoch, W., Greenspan, G., Alburn, H.E., Microbiological oxidation of fusidic acid. Experientia, VIII, 1966, 517.
10. Evans, L., Hedger, J.N., Brayford, D., Stavri, M., Smith, E., O'Donnell, G., Gray, A.I., Griffith, G.W., Simmon, G., Antibacterial hydroxy fusidic acid analogue from Acremonium crotocinigenum. Phytochemistry 67 (2006), 2110–2114.
11. Galal, A.M., Ibrahim, A.S., Mossa, J.S., El-Feraly, F.S., Microbial transformation of parthenolide. Phytochemistry 51 (1999), 761–765.
12. Godtfredsen, W.O., Vangedal, S., The structure of fusidic acid. Tetrahedron 18 (1962), 1029–1048.
13. Godtfredsen, W.O., Vangedal, S., On the metabolism of fusidic acid in man. Acta Chem. Scand. 20 (1966), 1599–1607.
14. Godtfredsen, W.O., Jahnssen, S., Lorck, H., Roholt, K., Tybring, L., Fusidic acid: a new antibiotic. Nature (London) 10 (1962), 193–897.
15. Hadara, K., Tomita, K., Fujii, K., Sato, N., Uchida, H., Yazawa, K., Mikami, Y., Inactivation of fusidic acid by pathogenic Nocardia. J. Antibiot. (Tokyo) 52:3 (1999), 335–339.
16. Hezari, M., Davis, P.J., Microbial models of mammalian metabolism: N-dealkylation of furosemide to yield the mammalian metabolite CSA using Cunninghamella elegans. Drug Metab. Dispos. 20 (1992), 882–888.
17. Holland, H.L., The mechanism of the microbial hydroxylation of steroids. Chem. Soc. Rev. 11 (1982), 371–395.
18. Ibrahim, A.S., Elokely, K., Ferreira, D., Ragab, A.E., 2018. Microbial oxidation of the fusidic acid side chain by Cunninghamella echinulata (submitted for publication).
19. Jones, E.R.H., The microbiological hydroxylation of steroids and related compounds. Pure Appl. Chem. 33:1 (1973), 39–52.
20. Kiran, I., Hanson, J.R., Hunter, A.C., The microbiological hydroxylation of some methoxysteroids by Cephalosporium aphidicola. J. Chem. Res. 5 (2004), 362–363.
21. Lange, B., Kremer, S., Sterner, O., Anke, H., Pyrene metabolism in Crinipellis stiptaria: identification of trans-4,5-dihydro-4,5-dihydroxypyrene and I-pyrenylsulfate in strain JK364. Appl. Environ. Microbial. 60 (1994), 3602–3607.
22. Lathe, R., Steroid and sterol 7-hydroxylation: ancient pathways. Steroids 5668 (2002), 1–11.
23. Pothuluri, J.V., Heflich, R.H., Fu, P.P., Cerniglia, C.E., Fungal metabolism and detoxification of fluoranthene. Appl. Environ. Microbial. 33 (1992), 269–277.
24. 13C NMR spectra of some selected fusidane derivatives. Magn. Res. Chem. 40 (2002), 471–473.
25. Reeves, D.S., The pharmacokinetics of fusidic acid. J. Antimicrob. Chemother. 20 (1987), 467–476.
26. Turnridge, J., Fusidic acid pharmacology, pharmacokinetics, and pharmacodynamics. Int. J. Antimicrob. Agents 12 (1999), S23–S34.
27. Von Daehne, W., Lorch, H., Godtfredsen, W.O., Microbial transformation of fusidane-type antibiotics, A correlation between fusidic acid and helvolic acid. Tetrahedron Lett. 47 (1968), 4843–4846.
28. Von Daehne, W., Godtfredsen, W.O., Rasmussen, P.R., Structure-activity relationships in fusidic acid –type antibiotics. Adv. Appl. Microbiol. 25 (1979), 95–145.
29. Von der Harr, B., Schrefmp, H., Purification and characterization of a novel extracellular Streptomyces lividans 66 enzyme inactivating fusidic acid. J. Bacteriol. 177 (1995), 152–155.
30. Zhang, D.L., Evans, F.E., Freeman, J.P., Duhart, B.J., Cerniglia, C.E., Biotransformation of amitriptyline by Cunninghamellla elegans. Drug Metab. Dispos. 23 (1995), l417–1425.
31. Zhang, D., Yang, Y., Leakey, E.A.J., Cerniglia, E.C., Phase I and phase II enzymes produced by Cunninghamella elegans for the metabolism of xenobiotics. FEMS Microbiol. Lett. 138:2–3 (1996), 221–226.